BWA
GILD icon

Basecamp Wealth Advisors’s Gilead Sciences GILD Stock Holding History

Basecamp Wealth Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$374K Hold
2,960
– – 0.07% 160
2026
Q1 		$413K Sell
2,960
-8
-0.3% -$1.12K 0.09% 143
2025
Q4 		$364K Buy
+2,968
New +$361K 0.08% 152

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Basecamp Wealth Advisors's GILD Position: Q2 2026 in Review

Basecamp Wealth Advisors held its Gilead Sciences (GILD) position steady in Q2 2026 at 2,960 shares worth $374K. The position accounts for 0.07% of the portfolio, ranked #160.

Basecamp Wealth Advisors first reported a position in GILD in Q4 2025 and has held it in 3 quarters since. The position peaked at $413K in Q1 2026. 2,257 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Basecamp Wealth Advisors held 2,960 shares of Gilead Sciences worth $374K as of Q2 2026.
  • Basecamp Wealth Advisors left its Gilead Sciences share count unchanged in Q2 2026.
  • Gilead Sciences made up 0.07% of Basecamp Wealth Advisors's portfolio in Q2 2026, its #160 holding.
  • Basecamp Wealth Advisors first reported a position in Gilead Sciences in Q4 2025 and has held it in 3 quarters since.
  • Basecamp Wealth Advisors's Gilead Sciences position peaked at $413K in Q1 2026.
  • 2,257 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Basecamp Wealth Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.